A Randomized, Double Blind, Placebo-controlled Crossover Study of Tolerability and Efficacy of Cannabidiol (CBD) on Tremor in Parkinson's Disease

Trial Profile

A Randomized, Double Blind, Placebo-controlled Crossover Study of Tolerability and Efficacy of Cannabidiol (CBD) on Tremor in Parkinson's Disease

Recruiting
Phase of Trial: Phase II

Latest Information Update: 08 Jun 2017

At a glance

  • Drugs Cannabidiol (Primary)
  • Indications Parkinson's disease; Tremor
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 08 Jun 2017 Results from open label part (n=6)presented at the 21st International Congress of Parkinson's Disease and Movement Disorders
    • 03 Nov 2016 Status changed from not yet recruiting to recruiting.
    • 13 Jul 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top